FOLR1 and cancer: Comparing in vitro cross-linking of FOLR1+ cancer cells and CD3+ T cells, cancer cell killing, and T-cell activation, bivalent FOLR1 binding significantly outperformed monovalent FOLR1 binding by chemically programmed biAbs.